GAMMA Investing’s Guardant Health GH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$145K Buy
965
+122
+14% +$13.3K 0.01% 1525
2026
Q1
$77.9K Buy
843
+35
+4% +$3.51K ﹤0.01% 1848
2025
Q4
$82.5K Buy
808
+226
+39% +$20.2K ﹤0.01% 1712
2025
Q3
$36.4K Buy
582
+133
+30% +$7.24K ﹤0.01% 2194
2025
Q2
$23.4K Buy
449
+34
+8% +$1.52K ﹤0.01% 2375
2025
Q1
$17.7K Buy
415
+266
+179% +$11.5K ﹤0.01% 2459
2024
Q4
$4.55K Buy
149
+114
+326% +$3.21K ﹤0.01% 2956
2024
Q3
$803 Buy
35
+23
+192% +$651 ﹤0.01% 3307
2024
Q2
$347 Sell
12
-5
-29% -$116 ﹤0.01% 3259
2024
Q1
$351 Buy
17
+7
+70% +$150 ﹤0.01% 3156
2023
Q4
$219 Buy
+10
New +$262 ﹤0.01% 3113

Other funds holding GH

GAMMA Investing's GH Position: Q2 2026 in Review

GAMMA Investing increased its Guardant Health (GH) stake by 14% in Q2 2026, buying an estimated $13.3K and bringing the position to 965 shares worth $145K. The position accounts for 0.01% of the portfolio, ranked #1525.

GAMMA Investing first reported a position in GH in Q4 2023 and has held it in 11 quarters since. 47 funds tracked by Wall St. Rank hold GH as of Q2 2026.

  • GAMMA Investing held 965 shares of Guardant Health worth $145K as of Q2 2026.
  • GAMMA Investing bought 122 Guardant Health shares in Q2 2026, an estimated $13.3K.
  • Guardant Health made up 0.01% of GAMMA Investing's portfolio in Q2 2026, its #1525 holding.
  • GAMMA Investing first reported a position in Guardant Health in Q4 2023 and has held it in 11 quarters since.
  • 47 funds tracked by Wall St. Rank held Guardant Health as of Q2 2026.

Based on GAMMA Investing's 13F filing for Q2 2026, filed 7 Jul 2026.